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Abstract
Multiple signalling pathways control the specification of endothelial cells (ECs) to become
arteries or veins during vertebrate embryogenesis. Current models propose that a cascade of
Hedgehog (Hh), Vascular Endothelial Growth Factor (VEGF) and Notch signalling acts
instructively on ECs to control the choice between arterial or venous fate. Differences in the
phenotypes induced by Hh, VEGF or Notch inhibition suggest that not all of the effects of Hh on
arterial-venous specification, are mediated by VEGF. We establish that full derepression of the Hh
pathway in ptc1;ptc2 mutants converts the posterior cardinal vein into a second arterial vessel that
manifests intact arterial gene expression, intersegmental vessel sprouting and haematopoietic stem
cell (HSC) gene expression. Importantly, whilst VEGF was thought to be absolutely essential for
arterial fates, we find that normal and ectopic arterial differentiation can occur without VEGF
signalling in ptc1;ptc2 mutants. Furthermore, Hh is able to bypass VEGF to induce arterial
differentiation in ECs via the calcitonin receptor-like receptor, thus revealing a surprising
complexity in the interplay between Hh and VEGF signalling during arteriovenous specification.
Finally, our experiments establish a dual function of Hedgehog during induction of runx1+ HSCs.
Introduction
Amongst the first fully differentiated cells to arise in the vertebrate embryo are the
mesodermally derived haematopoietic and endothelial lineages, which comprise the
circulatory system, itself the first functional organ system to develop. Unravelling the
signalling networks that govern the formation of the vasculature has taken on added
significance with the recent demonstration of the emergence of haematopoietic stem cells
(HSCs) from ventral endothelium of the dorsal aorta (DA) 1-3. In zebrafish, haematopoietic
and endothelial lineages arise from a common bipotential progenitor, the haemangioblast 4.
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Haemangioblasts are specified within ventral mesoderm, alongside unipotential
haematopoietic progenitors and angioblasts. These three cell types are transported via the
cellular rearrangements and morphological movements of gastrulation to reside as two
bilateral cell populations within the lateral plate mesoderm. The first major vessels of
vertebrate embryos form via vasculogenesis, whereby migratory angioblasts coalesce to
generate lumenised vessels. In zebrafish, angioblasts within the posterior lateral mesoderm
(PLM) migrate medially beneath the somites and coalesce ventral to the notochord and
hypochord at the midline. These cells form the major trunk vessels, the DA and PCV 5.
The exact regulation and timing of endothelial specification is an important developmental
question, but published data are currently difficult to reconcile. A genetic basis for arterial
and venous differentiation was established with the identification of Ephrin-B2 and EphB4
receptors as markers of arteries and veins respectively 6,7. Using lineage tracking, clusters of
ECs were identified within the zebrafish PLM, which either contributed to the DA or PCV,
but never both, leading to the suggestion that determination of arterial and venous fate
within ECs occurs prior to angioblast migration 8. The molecular basis of this proposed fate
restriction is unclear since differential expression of known arterial or venous markers
(ephrinb2a, kdrl and flt4) is observed after the migrating angioblasts arrive at the
midline 9-11; however, the first angioblasts to reach the midline and contribute to the DA
express activated ERK during their migration 12. Importantly, recent studies show that some
flk1/kdrl+(arterial) angioblasts migrate ventrally and contribute to the PCV following their
arrival at the midline 13. Taken together, these studies suggest endothelial progenitors are
specified as arterial or venous prior to circulation, but it is unclear whether they are fully
determined prior to migration to the midline.
The Notch signalling pathway is a key determinant in the establishment of arterial identity 9.
In mice, Notch receptors and ligands exhibit arterially restricted expression and targeted
inactivation of Notch pathway components results in defective arterial specification14.
Zebrafish mindbomb (mib) mutants, which are defective for Notch signalling, exhibit
arterial-venous shunts, defective PCV formation and reduced arterial gene expression, whilst
gridlock (grl) mutants, which contain a lesion in hey2, exhibit reduced arterial gene
expression and DA maturation defects 9,15,16.
Whilst Notch signalling guides arterial fate, elegant studies in zebrafish and more recently in
mouse, revealed Hh and VEGF signalling to act upstream of Notch in arterial
specification 17,18. Zebrafish sonic-you (syu) mutants, which lack midline Shha activity,
exhibit a drastic reduction in arterial gene expression. This failure to specify the DA
correctly was proposed to result from failure to express vegfa in the adjacent somites 17.
How this transcriptional activation occurs has not been addressed. Recently, a study
positioned Crlra downstream of Hh signalling and upstream of VEGF within this hierarchy
but the precise molecular details remain unclear 19. Whatever the exact mechanism of VEGF
induction, vegfa morphants exhibit reduced arterial gene expression, whilst vegfa
overexpression induces ectopic arterial differentiation and can rescue the loss of arterial
differentiation in syu mutant embryos, indicating its indispensability 17. VEGF binds to Kdrl
or Kdr, a receptor tyrosine kinase, thereby activating downstream Phospholipase C gamma1
(Plcg1) 20. Zebrafish kdrl and plcg1 mutants are defective in arterial but not in venous
specification 21,22. Less is known about venous determination; in mouse, active repression
of Notch signalling may occur in venous ECs 23. In zebrafish, PI3K signalling downstream
of VEGF may maintain venous identity via its ability to block MAPK signalling, which
itself favours arterial differentiation via activation of ERK 12.
Hh signalling inhibition in zebrafish embryos results in a failure to form two distinct trunk
axial vessels, a phenotype more severe than in embryos lacking VEGF signalling, implying
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that additional components act downstream of Hh to regulate arterial differentiation 9,17,20.
Consistent with this, ectopic lumenised vessels can be induced by exogenous Shh but not by
VEGF 24. Differences in the response of ECs to Hh and VEGF may account for this 25,
however, recent studies in mammals have revealed VEGF-independent roles for Hh
signalling in vascular lumenisation, yet the underlying mechanism remains unclear 18. In
zebrafish, activation of Hh signalling can induce arterial differentiation at the expense of
venous identity 26; here, we extend these findings through analysis of animals doubly mutant
for the Hh receptors Ptc1 and Ptc2, which exhibit constitutive activation of Hh
signalling 27,28. We show that Hh induces arterial differentiation at the expense of venous
fate, effectively converting the PCV into a second DA, which displays intact arterial
expression in addition to arterial characteristics, such as precocious vessel sprouting and
HSC gene expression. In addition, we show that in ptc1;ptc2 mutants, arterial differentiation
can occur independently of VEGF signalling, via a parallel pathway whereby Hh signalling
acts via Crlra to induce arterial differentiation. Given the high conservation of these genetic
hierarchies between zebrafish and mammals, the identification of Crlr signalling in parallel
with VEGF may account for the VEGF-independent effects of Hh signalling during
mammalian arterial development 18.
Materials and Methods
Zebrafish husbandry
Zebrafish (Danio rerio) embryos from wild-type, ptch1hu1602/+;ptch2tj222, smohi1640Tg/+,
plcg1t26480/+, Tg(fli1a:EGFP)y1/+, Tg(gata1:dsred)sd2/+ strains were raised at 28.5°C as
described 29.
Drug treatments
Purmorphamine (Chemistry Research Laboratory, South Parks Rd, Oxford, United
Kingdom; stock solution in DMSO: 2.5mg/ml) was used as previously described 30.
SU5416, Cyclopamine (Merck; stock solution 10mM in DMSO & 95% ethanol,
respectively) were used in E3 medium at a concentration of 2μM from tailbud and 50μM
from high stage, respectively.
Whole-mount RNA in situ hybridisation
Experiments were performed as previously described 11. Myc expression was detected using
anti-c-Myc primary antibody (9E10) (AbCam) (1:500) alongside anti-DIG antibody.
Embryos were incubated with Alexa-Fluor® 488 secondary antibody (Invitrogen) (1:200)
and imaged, followed by developing of in situ staining.
Crlra overexpression constructs
Full length crlra was amplified by RT-PCR with the SuperScript™ One-Step RT-PCR
System (Invitrogen) using the primers 5′-ggatcccgctccggtactctgacatc-3′, 5′-
ctcgagcacattgccatgttgagtgg-3′. The resulting BamHI/XhoI fragment was cloned into pCS2+.
Capped mRNA was generated using mMessage Machine® SP6 Kit (Ambion).
In situ probes
wnt16 probe was amplified using the primers 5′-cctttgtgctctcagggaag-3′, 5′-
gcgttgctctttatccttgc-3′ and cloned into pGem®-T-Easy (Promega). crlra probe was created
via PCR generated from IMAGE:7141310 (Source Bioscience) using primers 5′-
tggataaccgtattaccgcc-3′, 5′-cgcgcaattaaccctcactaaagcactagtcataccaggatc-3′.
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Fli1:Myc-dnPKA:IRES-EGFP construct
Construct was generated using the Tol2 kit via standard methods 31and the following
components; Fli1 enhancer/promoter, P5efli1EP 32, BamHI-XbaI fragment of pSP64T-
PKI 33 p3EIRES-EGFPpA 31. Embryos were injected at 1 cell stage with 25ng/ul Tol2
mRNA and Fli1:Myc-dnPKA:IRES-EGFP DNA.
Morpholino injections
Embryos were injected with 1nl crlra morpholino (Gene Tools) (0.67mM dissolved in
distilled water) 5′-agctcgctgtcatcttctttggcat -3′ 19; 0.5nl (0.5mM) Su(H) morpholino 5′-
caaacttccctgtcacaacaggcgc-3′ 34; 0.5nl (10ug/ul) kdr morpholino 5′-
gttttcttgatctcacctgaaccct-3′22; 0.5nl (10ug/ul) kdrl morpholino 5′-
ccgaatgatactccgtatgtcacctt-3′35.
Confocal imaging
Confocal images were collected using a Leica DM IRE2 microscope. Time-lapse confocal
images were collected using a PerkinElmer Ultraview Vox microscope. Images were
analysed using Volocity® to reconstruct a 3D representation.
Results
Zebrafish ptc1;ptc2 mutants show defective angioblast migration and fail to establish
circulation
Although both ptc1 heterozygous and homozygous embryos exhibit increased levels of Hh
signalling, vascular development is not obviously affected in either, and the circulatory loop
is established normally. Similarly, ptc2 homozygotes have no detectable defects in the
circulatory system 28. However, double mutant ptc1;ptc2 embryos, which exhibit
constitutive Hh signalling, by contrast, failed to establish circulation, resulting in pooling of
primitive erythrocytes in the intermediate cell mass and posterior blood island (Fig. 1A, B,
red arrowhead). This was further confirmed using the Tg(fli1a:EGFP)y1 and
Tg(gata1:dsred)sd2 transgenes 36,37 to visualise both developing vasculature and primitive
erythrocytes at onset of circulation. Using time-lapse confocal microscopy, we observed that
in wild-type embryos, primitive erythrocytes entered circulation via the PCV, as previously
described 13 (Fig. 1E, yellow arrowhead and Movie S1), whereas, in ptc1;ptc2 embryos,
they failed to enter the circulation, mainly residing within the PCV (Fig. 1F, yellow
arrowhead and Movie S2). Double mutant embryos also exhibit disorganised vasculature. In
wild-type embryos at 26hpf, the DA and PCV were juxtaposed following the entry of
primitive erythrocytes into circulation (Fig. 1E), whilst in ptc1;ptc2 mutants, the two axial
vessels were clearly separated (Fig. 1F). In more anterior regions, at 27 hpf, ptc1;ptc2
embryos exhibited a drastic reduction of endothelial cdh5 staining in the duct of Cuvier (Fig.
1C, D, black arrowheads), and the adjoining PCV (Fig. 1C, D, white arrowheads) indicating
these vessels were absent, which would explain the failure to establish a circulatory loop in
ptc1;ptc2 double mutants.
The medial migration of angioblasts is regulated by Hh signalling 11,26; thus, to investigate
whether a migration defect could contribute to the failure to form proper vessels, we used
the Tg(fli1a:EGFP)y1 transgene to follow medial migration of blood and endothelial
progenitors in live ptc1;ptc2 embryos (Fig. 1G-L). In control Tg(fli1a:EGFP)y1/+ embryos,
GFP+ angioblasts migrated such that by 12s, the first GFP+ DA angioblasts had reached the
midline (Movie S3 and Fig. 1G, white arrowhead). By 15s, these cells had begun to coalesce
into a vascular cord at the midline (Fig. 1H, white arrowhead), closely followed by
angioblasts, which contribute to the PCV (Fig. 1H, yellow arrowheads). By 18s, the vascular
cord extended posteriorly (Fig. 1I, white arrowhead), whilst some angioblasts remained
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more lateral and had not yet reached the midline (Fig. 1I, yellow arrowheads). In
Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos, by contrast, quantification using ImageJ revealed a
38% decrease in GFP+ cells throughout the embryo at 12s and 55% fewer angioblasts
migrated towards the midline at this stage (Movie S4 and Fig. 1J, white arrowheads), such
that by 15s, 43% fewer angioblasts had reached the midline, forming a discontinuous
vascular cord (Fig. 1K, white arrowheads) with many angioblasts present in more lateral
positions (Fig. 1K, yellow arrowheads). By 18s, the vascular cord extended
anteroposteriorly in Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos, yet remained discontinuous and
contained fewer GFP+ cells along the A-P axis (Fig. 1I, K, white arrowheads). Many GFP+
cells also remained in more lateral positions at 18s in Tg(fli1a:EGFP)y1/+;ptc1;ptc2
embryos (Fig. 1L yellow arrowheads). Thus, aberrant migration could contribute to the
observed circulation defect. We also examined the effect of Hh signalling deficiency on
angioblast migration using Tg(fli1a:EGFP)y1/+;smohi1640Tg embryos 38. In contrast to
recent studies 26, we observed that angioblasts in Tg(fli1a:EGFP);smohi1640Tg embryos
migrated in two waves, yet failed to coalesce into an endothelial cord at the midline (Movie
S6 and Fig. S1D-F). Taken together, these results suggest that either elevated or absent Hh
signalling results in impaired angioblast migration, implying that the levels of Hh signalling
perceived by angioblasts is important in their successful migration to the midline.
More detailed analysis of angioblast migration for a period of 17 hours from 16 somite stage
revealed that whilst the vasculature formed normally in Tg(fli1a:EGFP)y1/+ embryos
(Movie S7), Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos exhibited delayed formation of the DA,
resulting from aberrant medial migration of angioblasts, however, the DA ultimately formed
a continuous vessel in these embryos (Movie S8). Importantly, no angioblasts were observed
to migrate ventrally and contribute to the PCV, as described previously 13. Furthermore, in
Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos, angioblasts in the position of the PCV in the
posterior trunk were observed to migrate dorsally and contribute to the nascent DA (Movie
S8). VEGF has been shown to limit the ventral migration of angioblasts 13, thus, in ptc1;ptc2
mutants, where VEGF signalling is elevated (Fig. 3L, green arrowhead), angioblasts
migrated dorsally to contribute to the dorsal aorta, thereby underlining the importance of
VEGF signalling as a directional cue in this process.
ptc1;ptc2 mutants exhibit ectopic arterial differentiation at the expense of venous
differentiation, resulting in conversion of the PCV into an arterial vessel
During normal development, intersegmental vessels (ISVs) sprout from the DA from 24hpf
onwards, whilst venous ISVs sprout later between 1.5dpf and 2dpf 39,40. In ptc1;ptc2
embryos, by contrast, precocious ISV formation was clearly observed in the PCV at 27hpf
(Fig. 2B, C, D white arrowheads), suggesting that the PCV had acquired arterial
characteristics. Optical sectioning and 3D reconstruction confirmed that the sprouting ISVs
originated from the PCV and not the DA (Fig. 2F, white arrowhead). In addition to the
precocious PCV sprouts, ptc1;ptc2 mutants displayed atypical endothelial connections
between the DA and PCV (Fig. 2B, grey arrowheads), which were not present in control
embryos (Fig. 2A, C).
To evaluate the differentiation status of the vessels in ptc1;ptc2 embryos, we assayed arterial
and venous marker gene expression by in situ hybridisation. Expression of the VEGF
receptor kdrl normally exhibits an arterial bias, originally being present throughout the
nascent vasculature, but becoming downregulated in the PCV and restricted to the DA by
26-27hpf (Fig. 3A, red arrowhead). In ptc1;ptc2 mutants, by contrast, kdrl expression is
maintained in the PCV during vascular development (Fig. 3A, B, blue arrowheads). Whilst
the arterial marker ephrinb2a was ectopically expressed in the PCV (Fig. 3C, D, blue
arrowhead), the expression of aplnra in venous endothelium 41, was absent or substantially
downregulated in the PCV of ptc1;ptc2 mutants (Fig. 3E, F, blue arrowheads). Furthermore,
Wilkinson et al. Page 5
Blood. Author manuscript; available in PMC 2013 November 19.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
expression of the VEGF receptor flt4, which is restricted to the PCV at 27hpf, was
substantially downregulated in ptc1;ptc2 mutants (Fig. 3G, H, blue arrowheads). Ectopic
arterial gene expression in the PCV of ptc1;ptc2 mutants, combined with a loss of venous
gene expression indicates that the PCV had undergone a fate change and was converted into
an artery. We also assessed the onset of arterial gene expression within the ptc1;ptc2
mutants and did not observe any induction of arterial markers within pre-migratory
angioblasts (data not shown), however, ectopic expression of the arterial marker dll4 was
observed as early as 18s (Fig. S2A, B, red arrowheads) and was detectable in angioblasts
which had not yet reached the midline in ptc1;ptc2 mutants (Fig. S2D, asterisks). Similarly,
precocious midline expression of ephrinb2a was observed at 18s (Fig. S2E-H, red
arrowheads) and 19s (Fig. S2I-L, red arrowheads) in ptc1;ptc2 embryos. Thus, activation of
Hh can change both spatial and temporal profile of arterial gene expression.
Analysis of runx1+ HSCs in ptc1;ptc2 embryos confirms conversion of the PCV to an
arterial vessel, and indicates a dual function of Hh in their induction
Expression of the transcription factor runx1, is normally restricted to cells in the ventral DA
and also marks emerging definitive haematopoietic progenitors and HSCs 11,42,43. In
ptc1:ptc2 mutants, runx1 was expressed ectopically in the PCV, supporting the hypothesis
that the PCV had acquired arterial character (Fig. 3J, black arrowheads). Quantification of
the number of runx1+ cells in ptc1;ptc2 mutants revealed an 89% reduction (Fig. S3) and
these cells were absent from the DA (Fig, 3I, J, white arrowheads). Recent studies have
revealed a novel signalling pathway in the zebrafish somite 44, whereby somitic wnt16
signalling upstream of deltaC/deltaD was necessary for initiation of runx1 expression within
the DA. Since ptc1;ptc2 embryos exhibit somite patterning defects, we analysed wnt16
expression and found that it was persistently reduced in the somites of ptc1;ptc2 mutant
embryos from 10s onwards (Fig. 4A-D black arrowheads). In line with this, expression of
deltaD was lost within the somitic mesoderm from 10s (Fig. 4G, H black arrowheads), as
was deltaC (Fig. 4E, F; 27. That runx1 is expressed at all is surprising given the early
downregulation of wnt16 and deltaC/deltaD, however, we have previously demonstrated
that bmp4 expression is required for initiation of runx1 expression in the DA (30.
Furthermore, ptc1;ptc2 mutants exhibit strong upregulation of bmp4 within the pronephric
ducts (data not shown). It is therefore possible that Bmp signalling is able to rescue the loss
of somitic wnt16-DeltaC/D by inducing runx1 expression within arterial ECs close to the
source of bmp4. Taken together, these data indicate that ectopic Hh signalling affects runx1+
HSCs in two opposing ways: first by promoting arterial fate in the ventral vessel allowing
ectopic HSCs to form, but at the same time antagonising somitic wnt16 and deltaC/D,
leading to a reduction in overall HSC numbers.
The level of Hh and VEGF signalling determines the balance between venous and arterial
fates
Since Hh sits atop a signalling hierarchy that activates VEGF 17,19, we analysed vegfa
expression in ptc1;ptc2 mutants and found it was significantly up-regulated throughout the
trunk of mutant embryos (Fig. 3K, L, green arrowheads), consistent with previous studies 7.
We also treated wild-type embryos with the Smoothened agonist Purmorphamine (PMA)
from tailbud stage onwards 45, since PMA is capable of activating Hh signalling to a greater
level than that observed in ptc1 mutants, but less than that of ptc1;ptc2 mutants 30. PMA
treated embryos demonstrated increased kdrl and ephrinb2a expression within the DA (Fig.
S4A-D, red arrowheads). PMA treated embryos also retained higher kdrl expression within
the PCV (Fig. S4A, B blue arrowheads), whilst ephrinb2a was not ectopically induced. In
contrast to ptc1;ptc2 mutants, PMA treated embryos exhibited a moderate increase in vegfa
expression (Fig. S4G, H) and expression of the venous marker aplnra was considerably
reduced or absent in the PCV of PMA treated embryos (Fig. S4E, F, blue arrowheads).
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Taken together, these results indicate that the levels of Hh signalling and subsequent vegfa
expression are critical for the balance between arterial versus venous differentiation.
Arterial specification occurs independently of VEGF signalling in ptc1;ptc2 mutants
Upregulated vegfa expression in ptc1;ptc2 mutants (Fig. 3K, L, green arrowheads) implies
that the aberrant PCV specification was due to an increase in VEGF signalling. To address
this, we crossed the plcg1t26480 mutant 40, which blocks VEGF signalling downstream of its
receptor 20 into the Tg(fli1a:EGFP)y1/+;ptc1;ptc2 background. Whilst the vasculature of
Tg(fli1a:EGFP)y1/+ siblings exhibited normal ISV sprouting (Fig. 5A), ectopic ISVs were
observed in Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos (Fig. 5B). Furthermore, whereas the
axial vessels were juxtaposed in Tg(fli1a:EGFP)y1/+ embryos (Fig. 5A), the two vessels
could be observed discretely in Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos (Fig. 5B). In
contrast, no ISVs were present in Tg(fli1a:EGFP)y1/+;plcg1 embryos, indicating defective
angiogenesis arising from inhibition of VEGF signalling (Fig. 5C) 20,46,47. Whilst ISVs were
absent in Tg(fli1a:EGFP)y1/+;ptc1;ptc2;plcg1 embryos (Fig. 5D, E), the developing
vasculature consisted of a non-continuous dorsal vessel, which was not closely juxtaposed to
the ventral vessel. Expression of kdrl at 27hpf was reduced in the PCV (Fig. 5F blue
arrowhead) of Tg(fli1a:EGFP)y1/+ sibs and retained in the DA (Fig. 5F, red arrowhead) and
ISVs (Fig. 5F, yellow arrowhead). In contrast, ectopic kdrl expression was retained in both
vessels in Tg(fli1a:EGFP)y1/+;ptc1;ptc2;plcg1 mutant embryos (Fig. 5G, red arrowheads).
Consistent with this, arterial ephrinb2a was retained in all
Tg(fli1a:EGFP)y1/+;ptc1;ptc2;plcg1 embryos and demonstrated punctate expression
throughout the trunk in the position of the dorsal and ventral vessels (Fig. 5I, red
arrowheads). Both kdrl and ephrinb2a are strongly downregulated in plcg1 mutants 36.
Although the ptc1;ptc2;plcg1 triple mutant is expected to have no VEGF signalling,
bifurcations in the downstream signalling cascade imply that the use of alternative effectors
cannot be excluded. To control for this possibility, we employed an inhibitor of VEGF
signalling, SU5416, which acts at the level of the VEGF receptor, 48,49. We treated the
progeny of Tg(fli1a:EGFP)y1/+;ptc1/+;ptc2/+ × ptc1/+;ptc2/+ crosses, with high
concentrations of SU5416 (2 μM) from tailbud stage to ensure maximal inhibition of VEGF
signalling (Fig. S5). In treated ptc1;ptc2 mutants, expression of arterial markers such as dll4
and ephrinb2a were retained, albeit with reductions in the number of arterial ECs (Fig. S5h,
l, red arrowheads) relative to DMSO treated ptc1;ptc2 mutants (Fig. S5F, J, red arrowheads).
However, in SU5416 treated siblings, all arterial differentiation was absent (Fig. S5E, G, I,
K, red arrowheads). Moreover, ectopic arterial differentiation was retained in SU5416
treated ptc1;ptc2 mutants (Fig. S5H, L, red arrowhead). These results indicate that activation
of Hh signalling can induce arterial differentiation independently of VEGF signalling.
This result was surprising given previously demonstrated requirements for VEGF in arterial
differentiation. However, it remains formally possible that the levels of SU5416 used, which
were determined by its non-specific toxicity at higher doses, were insufficient to inhibit
elevated VEGF signalling in ptc1;ptc2 embryos. To address this issue, we asked whether the
same dose of SU5416 was sufficient to inhibit the effects of exogenous vegf121 mRNA.
Embryos were injected with 50pg vegfa mRNA, more than 2x higher concentration than that
sufficient to induce substantial ectopic arterial differentiation 17. As expected, embryos
injected with vegf121 mRNA and treated with DMSO exhibited ectopic ephrinb2a
expression throughout the trunk (Fig. S6B, red arrowhead). By contrast, 63% of injected
embryos treated with SU5416 exhibited total loss of ephrinb2a in the trunk (Fig. S6D, red
arrowhead), whilst the remaining 37% exhibited weak expression and no ectopic ephrinb2a
expression was observed (data not shown). These data clearly indicate that the concentration
of SU5416 employed is sufficient to inhibit very high levels of VEGF signalling.
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As a further control, we co-injected ptc1;ptc2 mutant embryos with morpholinos targeting
the VEGF receptors kdr and kdrl 22,35, which together are required to transduce the VEGF
signal. Combinatorial knock-down abolished arterial ephrinb2a expression in non-double
mutant sibs (Fig. S7A, C; red arrowhead). By contrast, ptc1;ptc2 mutant embryos retained
ectopic ephrinb2a expression (Fig. S7D, red arrowhead), although no vessel sprouting was
observed and fewer ephrinb2a+ cells were present (Fig. S7B, red arrowhead).
Finally, to demonstrate endothelial cell autonomy of Hedgehog signalling, we mosaically
activated Hedgehog signalling within ECs by co-injecting a Fli1:Myc-dnPKA:IRES-EGFP
DNA construct and Tol2 mRNA into embryos which were treated with cyclopamine, to
inhibit Hedgehog signalling and downstream VEGF (Fig. S8). Murine dnPKA is a well-
established activator of Hedgehog signalling 33. Uninjected embryos treated with
cyclopamine displayed a total absence of the early and late arterial markers dll4 (Fig. S8I, J,
black arrowheads) and ephrinb2a within the vasculature (Fig. S8D, F, black arrowheads;
and 11). By contrast, injected embryos treated with cyclopamine exhibited ECs co-
expressing Myc-dnPKA and dll4 (Fig. S8G, H, arrowheads) and ephrinb2a (Fig. S8K, L,
arrowheads). This rescue of arterial differentiation indicates that Hedgehog signalling is able
to act cell autonomously in ECs. Taken together, our triple mutant analysis, SU5416
exposure, VEGF receptor knock-down and demonstration of cell autonomy all show that
high levels of Hh signalling are able to induce arterial differentiation in a VEGF-
independent manner.
Arterial specification in ptc1;ptc2 mutants is dependent upon Notch signalling
To determine whether loss of Notch, which acts downstream of VEGF, could prevent
ectopic arterial differentiation in ptc1;ptc2 embryos, we injected a morpholino targeting
Su(H) 34, a protein essential for Notch signal transduction 50. Knockdown of Su(H) in non-
double mutant sibling embryos resulted in blood vessels (Fig.6A, B yellow arrowheads)
which failed to express arterial ephrinb2a (Fig. 6C, D, red arrowheads). Interestingly,
knockdown of Su(H) in ptc1;ptc2 double mutant embryos also resulted in a total loss of
vascular ephrinb2a expression (Fig. 6E, F red arrowheads). These data indicate that the
VEGF-independent signalling in ptc1;ptc2 embryos occurs upstream of Notch.
Knockdown of crlra in combination with VEGF inhibition prevents arterial differentiation in
ptc1;ptc2 mutants
Our finding that arterial differentiation can occur independently of VEGF signalling but is
dependent upon Notch, raises the important question of how Hh is able to bypass VEGF to
activate downstream target genes. We evaluated crlra, a downstream target of Hh with a role
in arterial induction 19. In wild-type embryos, crlra was diffusely and weakly expressed
throughout the somites (Fig. 7A, green arrowhead) but also weakly expressed in the DA
(Fig. 7A, red arrowhead). Conversely, in ptc1;ptc2 embryos, crlra was considerably
upregulated both in the somites (Fig. 7B, green arrowhead) and in the DA (Fig. 7B, red
arrowhead). Thus increased Crlra might account for the retention of arterial differentiation in
VEGF inhibited ptc1;ptc2 mutants.
Embryos were injected with crlra morpholino 19 and treated with SU5416. As previously
described, SU5416 treated wild-type embryos revealed a total absence of arterial
differentiation within the trunk vasculature (Fig. 7G, K; red arrowhead). In ptc1;ptc2
mutants, by contrast, treatment with SU5416 was unable to block arterial ephrinb2a
expression (Fig. 7H, L: blue arrowhead). Wild-type embryos injected with crlra morpholino
exhibited considerable downregulation of ephrinb2a (Fig. 7G, I, red arrowhead), whilst
those injected with crlra morpholino and treated with SU5416 displayed a total absence of
ephrinb2a throughout the trunk vasculature (Fig. 7M, red arrowhead). However, knockdown
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of crlra in ptc1;ptc2 embryos failed to prevent induction of ephrinb2a, which was expressed
ectopically (Fig. 7J, blue arrowhead). In ptc1;ptc2 embryos, only combined knockdown of
crlra and VEGF inhibition by SU5416 resulted in a total loss of ephrinb2a within the trunk
vasculature (Fig. 7N, red arrowhead).
A confounding aspect of the latter experiment is that crlra normally activates somitic VEGF
expression 19, so morpholino knock-down of crlra would be expected to lead to
downregulation both of Crlra and VEGF. To address whether activation of Hh can bypass
this function of Crlra, we assayed vegfa expression in ptc1;ptc2 mutant embryos and found
that in non-double mutant siblings, knockdown of crlra resulted in a decrease in somitic
vegfa expression (Fig. 7C, D, arrowhead) as previously reported 19. However, in ptc1;ptc2
mutants, crlra knockdown produced no observable difference in vegfa expression (Fig. 7F,
arrowhead) relative to uninjected ptc1;ptc2 mutants (Fig. 7E, arrowhead). We conclude that
Hh is indeed able to signal in parallel to Crlr to induce expression of vegfa. Taken together
with our observations that Notch signalling is required for arterial differentiation in
ptc1;ptc2 mutant embryos, these data indicate that Hh signalling is capable of inducing
arterial differentiation via Crlr independently of VEGF signalling, and, conversely, via
VEGF independently of Crlr, but that these signals converge again at the level of Notch
(Fig. 7O).
Discussion
Hedgehog signalling plays a crucial role in inducing arterial fate in the zebrafish embryo.
Elegant experiments by Lawson et al. (2002) revealed a hierarchy of signalling, initiated by
Hh and leading, via the induction of VEGF, to activation of hey2/gridlock and Notch
signalling to provide the final transcriptional output. More recently, an additional layer in
this control has been suggested involving the Crlr receptor 19. We have exploited the
constitutive activation of the Hh pathway in double mutant ptc1;ptc2 zebrafish embryos to
explore further the relationships between Hh and VEGF in early vessel formation. In
keeping with previous findings 17, we showed that activation of Hh leads to ectopic arterial
gene expression, ultimately resulting in the absence of a functional circulatory loop.
However, this endogenous hyper-activation of Hh signalling results in such strong
repression of venous development that a correctly specified PCV fails to develop: rather, a
second arterial vessel forms with an intact arterial marker signature, vessel sprouting and
initiation of HSC gene expression.
An earlier role has been postulated for Hh signalling in guiding endothelial migration 11,26.
We have demonstrated that the levels of Hh signalling received by angioblasts are critical
for their successful migration and that activation of the Hh pathway results in more severe
defects in initial angioblast migration towards the midline than loss of Hh signalling.
Previous studies have demonstrated that smo embryos exhibit a loss of arterial ECs and
concomitant gain in venous ECs and it was proposed that Hh is required cell autonomously
already within the PLM to regulate arterial-venous specificity 26. Importantly, we find that
in smohi1640 mutants, the first wave of angioblast migration, which largely contributes to
DA formation is not lost as has previously been reported 26. The discrepancy between our
findings and those of Williams et al., can most likely be explained by the higher resolution
of the confocal imaging of angioblast migration used in our study. However, smo embryos
lack arterial ECs, arguing that these two migratory waves are not differentially specified
prior to migration. In line with this, the Hh receptors ptc1 and ptc2 are not expressed in the
PLM 26,51 implying that cells of the PLM are unlikely to receive the Hh signal directly.
From our high-resolution time-lapse movies, we suggest that Hh signalling is most
important in the final stages of medial migration, since smo−/− angioblasts begin their
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medial migration normally, yet fail to form a continuous endothelial cord as they reach the
midline.
Interestingly, the arterial transformation of the ventral vessel leads to the generation of ISVs
from this location, in addition to formation of atypical connections between the two axial
vessels. Such connections have been observed in mutants with defects in arteriovenous
specification and it is likely that separation of the two vessels requires them to have different
molecular identities 14. Considering the body of data implicating VEGF in arterial induction,
we were initially surprised to find that mutation of plcg1, chemical ablation of VEGF
signalling, or knockdown of the VEGF receptors failed to block normal and ectopic
induction of arterial fates in double mutants. However, results from mice and also
differences in phenotypic strength of VEGF and Hh pathway mutants 18,25, indicated that
VEGF-independent functions of Hh signalling in these processes were likely. It is important
to stress, however, that under normal circumstances VEGF is essential for arterial induction.
Although Nicoli and co-workers suggested that Crlr was induced by Hh in the somites and
acted via VEGF, they could not exclude that direct effects of Crlr on ECs might occur.
Indeed our experiments indicate that such direct effects are likely since downregulation of
VEGF signalling is not sufficient to block arterial differentiation, arguing against a simple
Hh-Crlr-VEGF pathway. If somitic VEGF was the sole effector acting on ECs to induce
arterial fate, then inhibition of VEGF signalling in ptc1;ptc2 mutants should have resulted in
absence of arterial differentiation. Furthermore, it follows that vegfa overexpression would
also be predicted to phenocopy the vascular defects of ptc1;ptc2 mutants, a situation which
did not occur (Fig. S6B and 17).
The expression of crlra both in somites and ECs prompted us to analyse its potential role in
bypassing a normal requirement for VEGF in double mutants. Indeed crlra expression was
also induced in double mutants. Importantly, knock-down of crlra did not affect VEGF
upregulation in the somites, thus it is likely that Crlr acts in the ECs in VEGF-inhibited
double mutants. This finding raises several questions; most importantly how Crlr signalling
is regulated. A recent report indicated that in certain cells CRLR might act to “transactivate”
the VEGF receptor independently of the VEGF ligand 52. However, these authors also show
that the VEGF inhibitor we employed (SU5416) should block the action of both CRLR and
VEGF receptor activation. Our data show that CRLR functions in the presence of SU5416,
and thus this mechanism does not appear to be acting in zebrafish. A second simple
assumption would be that signals via VEGF and Crlr could both independently induce
arterial fate in ECs. This is not supported by experiments by us (Fig. S9) and others 19. crlr
overexpression is not sufficient to induce ectopic arterial fates in wild-types or rescue
arterial fates in Hh signalling-deficient embryos. In contrast, VEGF has been shown to be an
instructive factor with respect to arterial induction, and injection in wild-type or Hh
signalling-deficient embryos can induce ectopic arteries (Fig. S6B and 17). One interesting
assumption concerning the role of Crlr may be that it acts to enhance or modify Hh
signalling in ECs to induce arteries rather than act directly in the induction steps. We have
looked at mRNA expression of the classical Hh target ptc1 in crlr MO injected embryos but
did not see changes (RNW, unpublished observations). Another possibility is that crlr
overexpression by itself is not sufficient to increase signalling via this pathway and other
crucial components of this pathway also need to be upregulated, such as RAMPs or
Adrenomedullin ligands 53. Then we have to assume that Hh activation in ptc1;ptc2 mutants
is not just upregulating crlr but also those other components required for its activation. We
are currently evaluating this possibility.
The key outcome of Hh and VEGF signalling appears to be activation of Notch signalling.
To further position the Crlr signalling pathway within this hierarchy we inhibited Notch
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using a Su(H) morpholino capable of inhibiting the Notch pathway sufficiently to block
artery formation 34. We find that knock-down of Su(H) in ptc1;ptc2 mutants can block
artery formation, arguing that Crlr acts upstream of Notch. Thus, we suggest the model
shown in Fig. 7O for the signalling hierarchies involved in artery formation. Our results
show that while under normal circumstances VEGF is an essential signal for correct vessel
patterning in the zebrafish embryo, in situations of elevated Hh signalling, Crlr can bypass
this requirement. It may be interesting to evaluate whether similar mechanisms are at work
in other settings, for example, in tumours where Hh signalling is activated. It has been
reported that crlr downregulation inhibits tumour angiogenesis in a zebrafish xenograft
model 19. If this is a more widespread mechanism, inhibition of Crlr in addition to VEGF
inhibition could be important to evaluate as a therapeutic strategy, not only for anti-cancer
therapy, but also in the treatment of diseases such as diabetic retinopathy or macular
degeneration. Furthermore, the remarkable conservation of the genetic hierarchies involved
in arterial specification between zebrafish and mammals indicates that signalling via Crlr
represents a strong candidate pathway for recently identified, but as yet uncharacterised,
mechanisms of vessel patterning shown to be Hh-dependent and VEGF-independent 18.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Zebrafish ptc1;ptc2 double mutants fail to establish circulation and exhibit multiple
endothelial defects and defective angioblast migration
A, B) ptc1;ptc2 mutant (B) embryos at 27hpf showed somitic flattening (white arrowhead)
and loss of lens (asterisk). ptc1;ptc2 embryos showed non-circulating primitive erythrocytes
in the posterior ICM (red arrowhead). C, D) cdh5 expression in ptc1;ptc2 mutants (D)
revealed defective formation of the CCV/DC (black arrowheads) and PCV (white
arrowheads) compared to wild-type (C). E, F) Confocal image of trunk vasculature in
Tg(fli1a:EGFP)y1;Tg(gata1:dsred)sd2/+ (E) and Tg(gata1:dsred)sd2/+;ptc1;ptc2 (F)
embryos, anterior to the left, posterior right. The primary vasculature formed normally in
Tg(fli1a:EGFP)y1;Tg(gata1:dsred)sd2/+ embryos, and circulation commenced normally
(yellow arrowhead and Movie S1), whilst Tg(fli1a:EGFP)y1;Tg(gata1:dsred)sd2/+;ptc1;ptc2
embryos had disorganised vasculature, axial vessels were non-continuous along their A-P
axis (asterisks) and embryos lacked circulation (yellow arrowhead and Movie S2). G-L)
Confocal images using a Tg(fli1a:EGFP)y1/+ background to visualise migrating angioblasts
in indicated genetic backgrounds. Dorsal views are shown. G-I) Normal angioblast
migration in Tg(fli1a:EGFP)y1/+ embryos. (J-L) Fewer angioblasts migrated to the midline
in Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos and formed a discontinuous endothelial cord by
18s (Movie S3 and white arrowheads). Angioblasts were present in more lateral positions
(Movie S4 and L, yellow arrowheads) than in controls at the corresponding stage (I, yellow
arrrowheads). CCV common cardinal vein, PLM posterior lateral mesoderm, ICM
intermediate cell mass.
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Figure 2. ptc1;ptc2 mutants exhibit precocious vessel sprouting from the posterior cardinal vein
Confocal images of developing trunk vasculature in Tg(fli1a:EGFP)y1/+ (A, C, E) and
Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos at 27hpf (B, D, F), anterior is left, posterior right. A)
Normal trunk vasculature. Highlighted area is shown in panel C. B) Endothelial connections
between the DA and PCV were present in Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos (grey
arrowheads) and ectopic vessel sprouts arising from PCV were present (B, D white
arrowheads). Highlighted area is shown in panel d. 3D reconstruction showing transverse
plane of embryo shown in panels A, C (E) and embryo shown in panels B, D (F) shows the
sprouting capacity of ECs in the PCV region in ptc1;ptc2 mutants (white arrowhead).
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Figure 3. ptc1; ptc2 mutants exhibit ectopic arterial differentiation at the expense of venous
differentiation, resulting in conversion of the PCV into a second artery
Lateral views of trunk region are shown, oriented anterior to left, posterior right. A) kdrl
exhibited arterial preference in wild-type embryos (red arrowheads), but was present
ectopically in the PCV in ptc1;ptc2 embryos (B, blue arrowheads). C) ephrinb2a was
restricted to the DA in wild-type embryos (red arrowhead) but present ectopically in the
PCV in ptc1;ptc2 embryos (blue arrowheads). E) aplnra and flt4 (G) expression was
restricted to the PCV in wild-type embryos (blue arrowheads) and downregulated in
ptc1;ptc2 embryos (F, H, blue arrowheads). I) runx1 was restricted to the DA in wild-type
embryos (white arrowhead), downregulated in the DA of ptc1;ptc2 embryos (J, white
arrowhead) and ectopically expressed in the PCV of ptc1;ptc2 embryos (J, black
arrowheads). K) Increased trunk vegfa expression was present in ptc1;ptc2 embryos (L,
green arrowhead) in comparison to wild-type (K, green arrowhead).
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Figure 4. Somitic wnt16-deltaC/deltaD signalling required for HSC specification is abrogated in
ptc1;ptc2 mutants
Zebrafish flat mounts are shown with anterior to the left and posterior to the right. A, B)
somitic wnt16 expression is strongly downregulated in ptc1;ptc2 embryos at 10s (B, black
arrowheads) and this downregulation persisted at 15s stage (C, D black arrowheads). E, F)
Expression of deltaC was absent from the somitic mesoderm (SM) of ptc1;ptc2 embryos (F,
black arrowheads), but was present within the pre-somitic mesoderm (PSM) (F, grey
arrowheads). G, H) deltaD expression was strongly downregulated within the SM (H, black
arrowheads) and PSM (H, grey arrowheads) of ptc1;ptc2 embryos.
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Figure 5. Arterial specification occurs independently of VEGF signalling in ptc1;ptc2;plcg1 triple
mutants
(A-E) Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos formed two separate vessels, both with
sprouting capacity (B), whilst Tg(fli1a:EGFP)y1/+;plcg1t26480 embryos formed a single
vessel without ISV sprouts lacking arterial gene expression (data not shown)(C). Two
separate vessels were present in triple mutant embryos (D, zoomed view in E), but no ISVs
formed. kdrl (F, G) and ephrinb2a (H, I) expression indicated that the DA remained
duplicated in the triple mutants, albeit with fewer cells.
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Figure 6. Arterial specification in ptc1;ptc2 mutants is dependent upon Notch signalling
A) Tg(fli1a:EGFP)y1/+;ptc1;ptc2 embryos exhibit blood vessel formation (B, yellow
arrowhead) (n= 15/230) even following Su(H) morpholino injection (B, yellow arrowhead)
(n= 5/95) C) Normal DA ephrinb2a expression in uninjected non-double mutant embryos
(C, red arrowhead) (n=157/167) D) Loss of ephrinb2a in DA of non-double mutant Su(H)
morphants (red arrowhead) (n=159/180) E) Increased (red arrowhead), ectopic (green
arrowhead) ephrinb2a expression in uninjected ptc1;ptc2 embryos (n=10/167) F) Loss of
ephrinb2a in DA of ptc1;ptc2 Su(H) morphants (n=16/180)
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Figure 7. Knockdown of crlrla in combination with VEGF inhibition prevents arterial
differentiation in ptc1;ptc2 mutants
A) Wild-type somitic (green arrowhead) and DA crlra expression (red arrowhead) B)
Increased somitic (green arrowhead) and DA (red arrowhead) crlra expression in ptc1;ptc2
embryos. C) normal somitic crlra expression in uninjected wild type non-double mutant
embryos (arrowhead) (n=58/66) D) Decreased somitic crlra expression in non-double
mutant crlra morphants (n=58/71). E, F) No difference in crlra expression (arrowheads) was
detected between uninjected (n=5/66) and crlra morphant (n=4/71) ptc1;ptc2 embryos.
Uninjected wild-type sibs treated with SU5416 from tailbud until collection exhibited total
absence of vascular ephrinb2a expression (K, red arrowhead) (n=40/50) compared to
controls (G, red arrowhead) (n=46/49). SU5416 treated ptc1;ptc2 mutants showed increased
ephrinb2a (L, red arrowhead) and ectopic expression in PCV region (L, blue arrowhead)
(n=4/50), as did uninjected ptc1;ptc2 mutants (H, red and blue arrowheads) (n=3/49).
Uninjected SU5416 treated ptc1;ptc2 embryos exhibited no vessel sprouting in comparison
to DMSO treated ptc1;ptc2 embryos. ephrinb2a expression was downregulated in the DA of
non-double mutant crlra morphants treated with DMSO (I, red arrowhead) (n=78/96), whilst
non-double mutant crlra morphants treated with SU5416 exhibited a loss of vascular
ephrinb2a expression (M, red arrowhead) (n=165/183). ptc1;ptc2 crlra morphants treated
with DMSO showed strong ephrinb2a expression (J, red arrowhead), which was present
ectopically in the region of the PCV (J, blue arrowhead) (n=8/96), whilst vascular ephrinb2a
was absent in ptc1;ptc2 crlra morphants treated with SU5416 (N, red arrowhead)
(n=10/186). O) Proposed model for arterial differentiation.
Wilkinson et al. Page 21
Blood. Author manuscript; available in PMC 2013 November 19.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
